NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,049,556 | -69.5% | 6,814,214 | -21.6% | 0.10% | -67.4% |
| Q2 2023 | $360,654,256 | -30.3% | 8,690,464 | +1.0% | 0.31% | -34.3% |
| Q1 2023 | $517,414,551 | -20.4% | 8,603,501 | -2.9% | 0.47% | -31.1% |
| Q4 2022 | $650,162,811 | -4.0% | 8,863,842 | -0.6% | 0.68% | -2.9% |
| Q3 2022 | $677,300,000 | +6.9% | 8,914,191 | -2.2% | 0.70% | +7.4% |
| Q2 2022 | $633,578,000 | -18.1% | 9,116,230 | -2.4% | 0.65% | +19.9% |
| Q1 2022 | $773,890,000 | +7.2% | 9,340,845 | -2.9% | 0.54% | +36.9% |
| Q4 2021 | $721,906,000 | -33.7% | 9,615,168 | +2.6% | 0.40% | -30.4% |
| Q3 2021 | $1,088,478,000 | -47.2% | 9,369,705 | +0.7% | 0.57% | -43.4% |
| Q2 2021 | $2,063,165,000 | +76.1% | 9,301,081 | +4.9% | 1.00% | +53.4% |
| Q1 2021 | $1,171,635,000 | -18.0% | 8,863,932 | +7.3% | 0.66% | -17.7% |
| Q4 2020 | $1,429,497,000 | +58.1% | 8,261,075 | +1.7% | 0.80% | +27.8% |
| Q3 2020 | $904,355,000 | +93.0% | 8,124,645 | +2.8% | 0.62% | +74.5% |
| Q2 2020 | $468,692,000 | -10.0% | 7,903,720 | +2.2% | 0.36% | -36.7% |
| Q1 2020 | $520,983,000 | -22.8% | 7,736,618 | -3.4% | 0.56% | -13.5% |
| Q4 2019 | $674,917,000 | +4.3% | 8,008,982 | -7.4% | 0.65% | -11.4% |
| Q3 2019 | $647,117,000 | +15.9% | 8,653,618 | -2.0% | 0.74% | +24.3% |
| Q2 2019 | $558,287,000 | +44.2% | 8,829,449 | +9.8% | 0.59% | +39.6% |
| Q1 2019 | $387,263,000 | +157.1% | 8,039,525 | +78.7% | 0.42% | +116.3% |
| Q4 2018 | $150,610,000 | -18.5% | 4,498,524 | +27.5% | 0.20% | -2.0% |
| Q3 2018 | $184,821,000 | +90.9% | 3,527,100 | +14.0% | 0.20% | +92.3% |
| Q2 2018 | $96,823,000 | +61.5% | 3,093,395 | +12.5% | 0.10% | +48.6% |
| Q1 2018 | $59,942,000 | +391.2% | 2,749,639 | +355.2% | 0.07% | +366.7% |
| Q4 2017 | $12,203,000 | – | 604,117 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |